Medicine and Dentistry
Breast Cancer
100%
Recurrent Disease
44%
Cohort Analysis
42%
Tamoxifen
35%
Premenopause
29%
Malignant Neoplasm
28%
Adjuvant Endocrine Therapy
28%
Metastatic Breast Cancer
24%
Patient Compliance
21%
Cancer Prognosis
16%
Estrogen Receptor
16%
Hormone Therapy
14%
Tissue Microarray
14%
Image Analysis
14%
Cohort Effect
14%
Standardized Incidence Ratio
14%
Diabetes Mellitus
14%
Patient Registry
14%
Non Small Cell Lung Cancer
14%
Hazard Ratio
14%
Multidrug Resistance Associated Protein 2
14%
Single Nucleotide Polymorphism
14%
Case-Control Study
14%
Odds Ratio
13%
Cumulative Incidence
12%
Medical Record
10%
B-Cell Chronic Lymphocytic Leukemia
10%
Drug Therapy
9%
Odds Ratio
9%
Docetaxel
8%
Primary Tumor
7%
Cohabitation
7%
Disease
6%
Colorectal Cancer
6%
Population
6%
Pharmacokinetics
5%
CYP3A
5%
Logistic Regression Analysis
5%
Cancer Mortality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Recurrent Disease
41%
Tamoxifen
35%
Cohort Study
29%
Endocrine Therapy
28%
Chemotherapy
25%
Metastatic Breast Cancer
17%
Estrogen Receptor
16%
Multidrug Resistance-Associated Protein 2
14%
Taxane
14%
Congenital Malformation
14%
Patient Registry
14%
Non Small Cell Lung Cancer
14%
Case-Control Study
14%
Overall Survival
14%
Event Free Survival
10%
Malignant Neoplasm
9%
Docetaxel
8%
Disease
7%
Primary Tumor
7%
Comorbidity
6%
Pharmacokinetics
5%
CYP3A
5%
SLCO1B1
5%
Cancer Mortality
5%